SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001493152-23-026535
Filing Date
2023-08-03
Accepted
2023-08-03 09:29:21
Documents
20

Document Format Files

Seq Description Document Type Size
1 form424b3.htm 424B3 3295047
2 form424b3_001.jpg GRAPHIC 110406
3 form424b3_002.jpg GRAPHIC 29127
4 form424b3_003.jpg GRAPHIC 42949
5 form424b3_004.jpg GRAPHIC 45285
6 form424b3_005.jpg GRAPHIC 40534
7 form424b3_006.jpg GRAPHIC 27707
8 form424b3_007.jpg GRAPHIC 71151
9 form424b3_008.jpg GRAPHIC 32789
10 form424b3_009.jpg GRAPHIC 20078
11 form424b3_010.jpg GRAPHIC 33177
12 form424b3_011.jpg GRAPHIC 28224
13 form424b3_012.jpg GRAPHIC 42683
14 form424b3_013.jpg GRAPHIC 70060
15 form424b3_014.jpg GRAPHIC 80439
16 form424b3_015.jpg GRAPHIC 26243
17 form424b3_016.jpg GRAPHIC 49098
18 form424b3_017.jpg GRAPHIC 20082
19 form424b3_018.jpg GRAPHIC 22762
20 form424b3_019.jpg GRAPHIC 42992
  Complete submission text file 0001493152-23-026535.txt   4449457
Mailing Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022
Business Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022 (646) 908-2658
Ocean Biomedical, Inc. (Filer) CIK: 0001869974 (see all company filings)

IRS No.: 871309280 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-271392 | Film No.: 231138357
SIC: 2834 Pharmaceutical Preparations